GlassScriptPhysician profile
Jinping Chai
NPI 1952341265
$9,135.24
in general payments reported to CMS, 2019-2025
47 companies · $2,280 in 2025
The $2,280 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,665 · 2020: $559 · 2021: $933 · 2022: $871 · 2023: $1,168 · 2024: $1,661 · 2025: $2,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,108.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,706.56 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,349.37 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $932.23 | 2021-2025 | Vraylar, Ubrelvy, Linzess |
| Novo Nordisk INC | $675.33 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $440.72 | 2021-2025 | |
| Astellas Pharma US INC | $371.92 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $330.19 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $319.89 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.94 | 2019-2025 | Jardiance |
| Pfizer INC. | $291.15 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $284.56 | 2023-2025 | Gemtesa |
| Allergan, INC. | $262.98 | 2019-2020 | |
| Exact Sciences Corporation | $206.82 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Eisai INC. | $190.36 | 2021-2025 | |
| Amarin Pharma, INC. | $171.00 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinping Chai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.